Cutting-Edge Science, Potential Disease Treatments on Display at BIO 2006 Business Forum
WASHINGTON, D.C. (February 24, 2006) – The BIO 2006 Business Forum will feature biotechnology and pharmaceutical companies working to develop therapies for some of the world’s most devastating diseases and illnesses including many forms of cancer, diabetes and genetic disorders. The Business Forum runs April 9-12 at the McCormick Center in Chicago. It is a major part of the Biotechnology Industry Organization (BIO) 2006 Annual International Convention.
In addition to providing a venue for biotechnology and pharmaceutical companies to present cutting-edge science, the Business Forum offers companies the chance to network and meet one-on-one with academic research institutions and investors representing countries across the globe. The aim is to bring the business, financial and research communities together to discuss partnering, licensing and other opportunities.
“Historically, the Business Forum has been one of the most successful events at BIO’s Annual International Convention, generally drawing upwards of 3,000 registrants,” said Morrie Ruffin, BIO’s executive vice president of business development and capital formation.
“Last year, 954 companies participated in the partnering program and BIO scheduled 7,504 partnering meetings,” Ruffin said. “This year we expect greater success.”
Profiles of presenting companies and those participating in partnering meetings will be available at the Business Forum and online in the Company Profile section of the conference website. In addition, a complete schedule of company presentations will be available on this site at the Business Forum.
For more information on the BIO 2006 Annual International Convention, visit BIO’s website at http://www.bio.org/events/2006/.
Advance media registration for BIO 2006 is now available online. Registration is complimentary for credentialed members of the news media. To register, please visit http://www.bio.org/events/2006/reg/. Only reporters and editors working full-time for print or broadcast news organizations may register onsite with valid media credentials. All freelancers and online publications must register in advance by Friday, March 31, 2006.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.